Overview

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

Status:
Recruiting
Trial end date:
2026-10-01
Target enrollment:
Participant gender:
Summary
A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer
Phase:
Phase 2
Details
Lead Sponsor:
Aadi Bioscience, Inc.
Treatments:
Sirolimus